)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Anuh Pharma
Anuh Pharma (506260) investor relations material
Anuh Pharma Q2 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 26/27 earnings summary30 Oct, 2026
Executive summary
H1 FY27 revenue was ₹37,905.18 lakh, up 1.80% YoY; PAT rose 42.25% to ₹2,263.80 lakh, with higher-value mix supporting profitability.
Production increased 15.31% YoY to 987 MT; H2 priorities include rebuilding exports and pursuing 15–20% annual growth.
Unaudited results for the quarter and half year ended September 30, 2026, were approved following a limited review.
Financial highlights
Q2 revenue from operations was ₹18,524.14 lakh, versus ₹18,588.27 lakh in Q2 FY26 and ₹19,381.04 lakh in Q1 FY27.
Q2 PBT was ₹1,504.77 lakh versus ₹992.06 lakh YoY; H1 PBT was ₹3,197.58 lakh versus ₹2,087.37 lakh.
Q2 PAT was ₹1,121.31 lakh versus ₹761.25 lakh YoY; H1 PAT was ₹2,263.80 lakh versus ₹1,591.37 lakh.
H1 operating profit rose 26.23% to ₹78.11 Cr, with margin at 20.61% versus 16.62%; EBITDA increased 39.11% to ₹3,691.57 lakh.
Q2 revenue declined 4.42% QoQ to ₹185.24 Cr; EBITDA fell 9.36% to ₹17.55 Cr and PAT fell 1.85% to ₹11.21 Cr.
Outlook and guidance
15–20% annual growth is targeted, supported by API volume expansion, regulated-market growth, process innovation and cost optimization.
Plans include export diversification, compliance and capacity investment, and development of Bisoprolol Fumarate, Brivaracetam and Tegoprazan Fumarate.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Anuh Pharma
- Sales and exports grew as the new Tarapur API facility came on stream.506260
Q4 06/07 - Profit rose despite weaker sales; a 1:1 bonus issue and 50% dividend were proposed.506260Q4 97/98
- Profit rose despite falling sales, with export growth and deposit-compliance concerns.506260Q4 98/99
- Sales rose 50% and exports climbed to Rs 99.03m as PAT reached Rs 24.34m.506260Q4 99/00
- PAT rose to ₹39.80m as exports grew and Tarapur capacity expansion began.506260Q4 01/02
- Sales grew 11.6%, exports surged, and PAT softened; dividend rose to ₹12.50/share.506260Q4 02/03
- Sales rose 50.1%, exports 46.5%, and PAT reached Rs 60.3m in FY04.506260Q4 03/04
- Profit fell amid export weakness; a new factory targets ~70% more capacity.506260Q4 04/05
- Sales rose 49.14%, PAT grew 41.57%, and the new factory came on stream.506260Q4 05/06
Next Anuh Pharma earnings date
Q3 26/275 Feb, 2027
Anuh Pharma
Next Anuh Pharma earnings date
Q3 26/275 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Anuh Pharma Limited is a pharmaceutical company primarily engaged in the manufacturing and export of active pharmaceutical ingredients (APIs). The company produces APIs for a range of therapeutic segments, including antibiotics, antihistamines, and antituberculosis agents. Its operations include chemical synthesis, quality control, and regulatory compliance to meet the standards of domestic and international markets. Anuh Pharma Limited serves pharmaceutical manufacturers globally and may also offer contract manufacturing services. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.